- Home
- MSI vs INM Comparison
MSI vs INM Comparison
Compare MSI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSI
- INM
- Stock Information
- Founded
- MSI 1928
- INM 1981
- Country
- MSI United States
- INM Canada
- Employees
- MSI N/A
- INM N/A
- Industry
- MSI Radio And Television Broadcasting And Communications Equipment
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- MSI Technology
- INM Health Care
- Exchange
- MSI Nasdaq
- INM Nasdaq
- Market Cap
- MSI 67.6B
- INM 3.2M
- IPO Year
- MSI N/A
- INM N/A
- Fundamental
- Price
- MSI $410.12
- INM $2.30
- Analyst Decision
- MSI Strong Buy
- INM
- Analyst Count
- MSI 9
- INM 0
- Target Price
- MSI $505.11
- INM N/A
- AVG Volume (30 Days)
- MSI 831.6K
- INM 46.6K
- Earning Date
- MSI 05-01-2025
- INM 05-13-2025
- Dividend Yield
- MSI 1.06%
- INM N/A
- EPS Growth
- MSI 45.79
- INM N/A
- EPS
- MSI 11.91
- INM N/A
- Revenue
- MSI $10,956,000,000.00
- INM $4,832,013.00
- Revenue This Year
- MSI $6.73
- INM N/A
- Revenue Next Year
- MSI $5.79
- INM N/A
- P/E Ratio
- MSI $34.46
- INM N/A
- Revenue Growth
- MSI 7.45
- INM N/A
- 52 Week Low
- MSI $332.98
- INM $1.72
- 52 Week High
- MSI $507.82
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- MSI 42.55
- INM 34.09
- Support Level
- MSI $397.00
- INM $2.70
- Resistance Level
- MSI $444.37
- INM $3.20
- Average True Range (ATR)
- MSI 9.12
- INM 0.23
- MACD
- MSI -1.65
- INM -0.05
- Stochastic Oscillator
- MSI 27.70
- INM 5.26
About MSI Motorola Solutions Inc.
Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm's revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment and dispatch software. Most of Motorola's revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.